Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population

SUMMARY: Our aim was to evaluate the gap in osteoporosis treatment and the impact of osteoporosis treatment on subsequent fragility fractures. We found osteoporosis medication use lowered risk of subsequent fractures by 21% and that black race, higher CCI scores, dementia, and kidney diseases reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshishian, A., Boytsov, N., Burge, R., Krohn, K., Lombard, L., Zhang, X., Xie, L., Baser, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524851/
https://www.ncbi.nlm.nih.gov/pubmed/28536737
http://dx.doi.org/10.1007/s00198-017-4072-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524851/
https://www.ncbi.nlm.nih.gov/pubmed/28536737
http://dx.doi.org/10.1007/s00198-017-4072-6

Ejemplares similares